REGULATORY

• Pay Heed to Company Burdens for Cost-Effective Evaluations, Kamoya Tells Chuikyo
  May 28, 2015

• MHLW Eyes Budget Request to Set Up Cost-Effective Analysis Regime, Report Due Out Summer
  May 28, 2015

• MHLW Approves MSD’s Pegintron for Adjuvant Therapy for Malignant Melanoma
  May 27, 2015

• MHLW to Set Generic Share Target of 80% by FY2020-End: Shiozaki
  May 27, 2015

• MHLW Notifies of Package Insert Change for Plavix
  May 27, 2015

• ICH Likely to OK Brazil, China as Assembly Members at Fukuoka Confab
  May 26, 2015

• MHLW Grants Orphan Designation for Rituximab, Metirosine
  May 26, 2015

• PAFSC 1st Committee to Review Lilly’s GLP-1 Receptor Agonist Dulaglutide on June 5
  May 25, 2015

• Editor’s Pick: Five Healthcare News Headlines for May 11 - May 24
  May 25, 2015

• Considerable Resolve Needed for Proposed 80% Generic Target: JGA
  May 25, 2015

• JSGM President Muto Calls for “Favorable Environment” to Promote Use of Biosimilars
  May 25, 2015

• Govt Panel Members Renew Call for Annual Drug Price Cuts, Amari Says Conclusion Out after 2016-2018 Consecutive Revisions
  May 20, 2015

• Panel OKs Sovaldi for Medical Subsidy, Monthly Copay at 10,000-20,000 Yen
  May 19, 2015

• Generic Drug Use May Reach 60% Target Ahead of Schedule, but Raising Target to 80% Would Be “Difficult”: Director Jo of EAD
  May 18, 2015

• PAFSC Second Committee to Review Safety Information of Takeda’s Hib Vaccine on May 28
  May 18, 2015

• MHLW Announces 196 Newly Designated Intractable Diseases
  May 15, 2015

• PAFSC Second Committee to Discuss Gilead’s Combination Hepatitis C Treatment on May 28
  May 15, 2015

• Chuikyo Reps Discuss HTA, Re-Pricing as Sovaldi Lands in Japan
  May 14, 2015

• Chuikyo Approves Listing of 5 Drugs with Expected Peak Sales of Over 10 Billion Yen
  May 14, 2015

• Sovaldi’s 5 Million Yen Price Tag OK’d for 12-Week Regimen, Listing on May 20
  May 13, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 302
• 303
• 304
• 305
• 306
• 307
• 308
• 309
• 310
• …
• Next ›
• 最終 »